Department of Immunology, University of Manitoba, Winnipeg, MB, Canada.
Mucosal Immunol. 2012 Nov;5(6):605-9. doi: 10.1038/mi.2012.74. Epub 2012 Aug 22.
Asthma is a complex disease of the lungs, which is characterized by airway inflammation and airway hyperresponsiveness (AHR). Alveolar macrophages (AMs), one of the prominent immune system cells found in the airways, have been implicated in the development and progression of asthma. AMs constitute a unique subset of pulmonary macrophages, which serve as a first line of defense against foreign invaders to the lung tissue. In addition, based on human and animal studies, they have also been found to regulate pro- and anti-inflammatory responses in the airways, suggesting that these cells have a critical role in asthma. In this review, our focus is to evaluate the relevance of AMs in the context of asthma, and the underlying mechanisms that regulate their functions.
哮喘是一种肺部的复杂疾病,其特征为气道炎症和气道高反应性(AHR)。肺泡巨噬细胞(AMs)是气道中突出的免疫系统细胞之一,与哮喘的发生和发展有关。AMs 构成了肺巨噬细胞的一个独特亚群,作为肺组织抵御外来侵略者的第一道防线。此外,基于人体和动物研究,还发现它们调节气道中的促炎和抗炎反应,表明这些细胞在哮喘中具有关键作用。在这篇综述中,我们的重点是评估 AMs 在哮喘背景下的相关性,以及调节其功能的潜在机制。